Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ketone doai
Reexamination Certificate
2006-11-07
2006-11-07
Padmanabhan, Sreeni (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ketone doai
C514S690000, C514S693000, C514S703000, C514S725000
Reexamination Certificate
active
07132458
ABSTRACT:
This invention features fractionated oxidized carotenoid or retinoid mixtures, and individual components thereof, which are useful as cell-differentiation-inducing, anti-proliferative, anti-metastatic and anti-tumor agents. The mixtures and compounds of the invention can be used alone or in combination with other anticancer agents for the treatment of cancer.
REFERENCES:
patent: 4105855 (1978-08-01), Schulz et al.
patent: 4127455 (1978-11-01), Schulz et al.
patent: 4351346 (1982-09-01), Brummer et al.
patent: 4996069 (1991-02-01), de Hay et al.
patent: 5084292 (1992-01-01), Van Dort et al.
patent: 5097063 (1992-03-01), Moldt
patent: 5225604 (1993-07-01), Moldt
patent: 5310554 (1994-05-01), Haigh
patent: 5358915 (1994-10-01), Nebergall et al.
patent: 5475006 (1995-12-01), Burton et al.
patent: WO96/05160 (1996-02-01), None
“Remington: The Science and Practice of Pharmacy” (20th ed.), A.R. Gennaro, 2000, p. 858-861,963.
Hardman et al. “Goodman & Gilman's The Pharmacological Basis of Therapeutics” (9th ed, 1996) p. 51 and 57-58.
Verma et al., Cancer Res. (1980), 40(7), 2367-71.
Anon et al. Nutr. Rev. (1979), 37(5), 153-6.
Oyler et al, Characerization of Autoxidation Products of Retinoic Acid, 1989, Tetrahedron, vol. 45, issue 24, pp. 7679-7694.
Brouwer, M.S. et al., “A New Synthesis of 4-OR*-3-penten-1-ynes (C5-fragment) as a Tool for The Preparation of Vitamin A1†” J. of the Royal Netherlands Chem. Soc. 98:5, 316-320 (1979).
Clark, K.B. et al., “Retinoic Acid Oxidation at High Oxygen Pressure: Evidence for Spin-Forbidden Direct Addition of Triplet Molecular Oxygen” J. Am. Chem. Soc. 119:40, 9560-9561 (1997).
R. Peto et al., “Can Dietary Beta-Carotene Materially Reduce Human Cancer Rates?”,Nature(1981) 290:201-208.
N.I. Krinsky, “Actions of Carotenoids in Biological Systems”,Annu. Rev. Nutr. (1993) 13:561-587.
D.L. Hill and C.J. Grubbs, “Retinoids and Cancer Prevention”,Annu. Rev. Nutr. (1992) 123:161-181.
Burton and Ingold,“β: An Unusual Type of Lipid Antioxidant”,Science(1984) 224:569-573.
Raphael C. Mordi, et al. “Exploratory Study of β-Carotene Autoxidation” (1991)Tetrahedron32(33):4203-4206.
Raphael C. Mordi et al., “Oxidative Degradation of β-Carotene and β-Apo-8'-carotenal” (1993)Tetrahedron49(4):911-928.
Alaoui-Jamali et al., “In VivoReversal of Doxorubicin Resistance by a New Tiapamil Analog Roll-29331”,J. Pharmacol. Exp. Ther. (1993) 264(3):1229.
Pure Appl. Chem. (1985) 57:717-722, Matthews-Roth.
Oyler, Tetrahedron, vol. 45, No. 24, pp. 7679-7694, (1989).
Kanasawud, P.; Crouzet, J. C.; Mechanism of Formation of Volatile Compounds by Thermal Degradation of Carotenoids in Aqueous Medium. 2. Lycopene Degradation. J. Agric. Food Chem. 1990, 38, 1238-1242.
Arya Prabhat
Burton Graham
Daroszewski Janusz
Phipps Jenny
Bieker-Brady Kristina
Chemaphor Inc.
Clark & Elbing LLP
Cotton Abigail M.
Padmanabhan Sreeni
LandOfFree
Oxidized carotenoid fractions and ketoaldehyde useful as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxidized carotenoid fractions and ketoaldehyde useful as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxidized carotenoid fractions and ketoaldehyde useful as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3687453